Cencora, Inc. COR

What this company does

Cencora distributes brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers in the United States and select global markets. It also furnishes healthcare providers and pharmaceutical manufacturers with related services, including data analytics, outcomes research, and reimbursement and pharmaceutical consulting services. As of September 30, 2025, the company had more than 51,000 employees globally, of which approximately 47,000 were full-time and approximately 41% were based in the United States. Its top 10 customers, including governmental agencies and group purchasing organizations, accounted for approximately 66% of revenue, with Walgreens and Boots together representing approximately 25% and Evernorth Health Services approximately 13%. The business is organized geographically around the products and services it provides, and its operations are comprised of two reportable segments, U.S. Healthcare Solutions and International Healthcare Solutions. The parent of the group is Cencora, Inc., a Delaware corporation.

Written from the business description in Cencora, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 25 November 2025. Every sentence was checked against that document before publication.